Bradley Schaeffer
Foot & Ankle Surgery · New York, NYNPI 1952701195
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,850 of the $13,053 with a category attached, or 67.8%. Pacira Pharmaceuticals Incorporated accounts for 67.8% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $10,216 and has fallen 98.0% since, to $205 in 2025.
Across 82 payments — averaging $159.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$9K
- Treace Medical Concepts, Inc.$2K
- Medical Device Business Services, Inc.$1K
- Stryker$501
- Gilead$344
- Amgen$269
- plus $294 from 12 others
What the payments were for
- Consulting fees$8,85068%
- Travel & lodging$2,38818%
- Food & beverage$1,80514%
- Education$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 1 | $8,850 |
| Treace Medical Concepts, Inc. | 7 | $1,613 |
| Medical Device Business Services, Inc. | 6 | $1,182 |
| Stryker(2 entities) | 7 | $501 |
| Gilead | 15 | $344 |
| Amgen | 28 | $269 |
| Paragon 28, Inc. | 3 | $48 |
| Zimmer Biomet | 2 | $45 |
| Merck | 3 | $38 |
| Smith+Nephew | 2 | $37 |
| GSK | 1 | $29 |
| Organogenesis Inc. | 1 | $16 |
| Bioventus LLC | 1 | $15 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $14 |
| Sebela Pharmaceuticals Inc. | 1 | $14 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $13 |
| Tactile Systems Technology Inc | 1 | $13 |
| Royal Biologics, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPAREL$8,850
- Iovera$8,850
- Zilretta$8,850
- Lapiplasty System$1,504
- VA-LCP PLATES & SCREWS$998
- ORTHOLOC 2 LAPIFUSE$248
- AUGMENT INJECTABLE$143
- CARTIVA$124
- CARTIVA SYNTHETIC CARTILAGE IMPLANT$105
How this compares
$13,053 in reported general payments places this provider in the 85th percentile of 652 foot & ankle surgery providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 15 | $85 |
| Meloxicam | 26 | $53 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in New York
- Jonathan DelandNew York$4M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$597K
- John KennedyNew York$534K
- Stuart MogulNew York$131K
- Deena HornNew York$93K
- John DoolanNew York$87K
- Jason SnyderNew York$79K
- Meghan KellyNew York$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.